The company said that in its most recent clinical trial, the discontinuation rate due to side effects increased with the dosage, with the highest discontinuation rate, 11.3%, at the highest dosage of 12 mg
Paired with a strong GLP-1 agonism that counters its hyperglycemic effect via insulin secretion, the glucagon arm becomes an accelerator of energy expenditure and lipid catabolism particularly relevant for hepatic steatosis
For someone interested in pharmaceutical marketing, this evolving GLP-1 landscape is fascinating, it shows how science, competition, and market strategy intersect to shape the future of healthcare
In a healthy scalp, approximately 85% of hair is in the anagen phase and 15% in the telogen phase
These seem to be working well